USANA Health Sciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.6% | +3.0% | -6.6% | -5.9% | +6.7% | +16.8% | -5.5% | -9.4% | +5.9% | +10.6% | -10.8% | – | |
| – | -1.2% | +2.2% | -4.5% | -3.0% | -0.6% | +42.8% | -4.7% | -15.7% | +1.2% | +20.3% | -18.7% | – | |
| – | +4.9% | +3.3% | -7.1% | -6.7% | +8.7% | +10.3% | -5.7% | -7.3% | +7.2% | +7.9% | -8.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.3% | +9.6% | -5.9% | +1.3% | +19.7% | +24.7% | -10.4% | +4.9% | -9.2% | +13.0% | -6.7% | – | |
| – | +1.1% | +3.5% | -3.8% | -6.0% | +14.9% | +6.3% | -6.9% | +1.5% | -2.5% | +10.9% | +10.2% | – | |
| – | +37.6% | +1.9% | -27.7% | -12.6% | -47.4% | +90.9% | +6.7% | -92.7% | +1,309.2% | -19.6% | -244.1% | – | |
| – | +237.2% | -64.1% | -1.9% | -3.9% | +163.3% | +218.6% | -37.0% | -81.1% | +151.0% | +95.1% | -100.0% | – | |
| – | +29.6% | +1.9% | -25.5% | -7.9% | -44.0% | +60.5% | +12.4% | -90.5% | +132.8% | +270.2% | -222.2% | – | |
| – | +7.2% | +7.4% | -7.6% | -18.1% | -25.7% | +25.3% | +12.4% | +1.0% | -31.7% | +47.4% | +6.4% | – | |
| – | +47.8% | -1.4% | -36.9% | +1.7% | -57.7% | +109.7% | +2.7% | -167.6% | – | – | -384.5% | – | |
| – | +22.9% | +2.0% | -19.5% | -6.7% | -32.1% | +66.6% | +4.7% | -60.2% | +27.8% | +74.8% | -174.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.